Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05465538 · ClinicalTrials.gov registry record · Phase 1
SV2A in Older Adults
A Phase 1 study of Cannabis Use, sponsored by Yale University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT05465538 is a Phase 1 study of Cannabis Use that is actively recruiting participants, run by Yale University. The registered enrollment target is 24 participants, below the 279-participant average among 44 other Cannabis Use trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05465538, a Phase 1 study of Cannabis Use, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of the study is to examine the effect of cannabis use on brain synaptic density among older adults using \[11C\]UCB-J PET imaging.
Conditions Studied
Interventions
- DRUG [11C]UCB-J PET
Study Locations (1)
Connecticut
- Conneticut Mental Health Center - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2022-07-06 |
| Est. Completion | 2027-09-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05465538
The ClinicalTrials.gov registry entry for NCT05465538 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 279-participant average among 44 other Cannabis Use trials with a reported enrollment target (91% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cannabis Use appearing as the primary indexed condition, and to 1 intervention - of which [11C]UCB-J PET is the first listed.
NCT05465538 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT05465538 about?
NCT05465538 is a clinical study titled "SV2A in Older Adults". The aim of the study is to examine the effect of cannabis use on brain synaptic density among older adults using \[11C\]UCB-J PET imaging.
What is the current status of trial NCT05465538?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2022-07-06. Estimated completion is 2027-09-30.
What conditions does trial NCT05465538 study?
This clinical trial studies the following conditions: Cannabis Use.
What interventions are being tested in trial NCT05465538?
The interventions under investigation include: [11C]UCB-J PET (DRUG).
Who is sponsoring clinical trial NCT05465538?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05465538 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Cannabis on Cigarette Use Behavior
RECRUITING · Phase 1
-
HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)
RECRUITING · Phase 1
-
Maternal Choline Supplementation and Cannabis Use During Pregnancy: Impact on Early Brain Development
RECRUITING · Phase 1
-
The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles
RECRUITING · Phase 1
-
Effect of Cannabis on E-Cigarette Use Behavior
RECRUITING · Phase 1
-
Effect of Lorcaserin on Cannabis Withdrawal and Self-administration
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.